CDC's main guidance hub for infection prevention in K–12 schools, covering respiratory and gastrointestinal illness, environmental controls, and exclusion policies.
https://www.cdc.gov/children-and-school-preparedness/infection-prevention/index.htmlPractical, everyday school-based interventions recommended by the CDC for reducing transmission of common communicable diseases, including hand hygiene, respiratory etiquette, and surface cleaning.
https://www.cdc.gov/children-and-school-preparedness/php/interventions/everyday-actions-for-schools.htmlA systematic review of 158 studies summarizing the most effective non-pharmaceutical interventions for K–12 schools. Key findings: improved ventilation reduces infection risk by up to 74%; respiratory illness accounts for 59% of school closures, gastrointestinal illness for 20%.
https://www.cdc.gov/children-and-school-preparedness/infection-prevention/docs/IPC-Science-Brief_508.pdfCDC page on influenza risk in children, covering hospitalization rates (6,000–25,000 per season for children under 5), pediatric flu deaths (37–199 annually), and the finding that ~80% of child flu deaths occur in unvaccinated children.
https://www.cdc.gov/flu/highrisk/children.htmlArchived CDC guidance page specifically for school administrators and childcare providers on responding to seasonal influenza outbreaks, including when to close schools and how to communicate with families.
https://archive.cdc.gov/www_cdc_gov/flu/school/index.htmArchived CDC symptom list for COVID-19, including common, less common, and emergency warning signs. Used to develop the symptom sections of the COVID-19 factsheets at all three age levels.
https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/symptoms-testing/symptoms.htmlArchived CDC operational guidance for schools during the COVID-19 pandemic, addressing ventilation, masking, testing, quarantine, and layered prevention strategies for K–12 and early care settings.
https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/community/schools-childcare/k-12-childcare-guidance.htmlCDC Emerging Infectious Diseases journal article examining Long COVID's impact on school attendance and daily functioning in school-age children, including cognitive symptoms and exercise intolerance that affect classroom performance.
https://wwwnc.cdc.gov/eid/article/31/14/25-1035_articleCDC page on RSV risk in young children. RSV is the leading cause of infant hospitalization in the U.S. Most children are infected by age 2, and 20–30% of infections in young children lead to lower respiratory tract disease.
https://www.cdc.gov/rsv/infants-young-children/index.htmlCDC overview of RSV symptoms including runny nose, cough, wheezing, and bronchiolitis in young children, with guidance on when to seek medical care. Used for the symptoms section of the RSV factsheets.
https://www.cdc.gov/rsv/symptoms/index.htmlCDC clinical guidance on RSV immunization, including nirsevimab (Beyfortus) monoclonal antibody prophylaxis for infants and RSVpreF maternal vaccine. Used for the prevention sections of the RSV factsheets.
https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/infants-young-children.htmlCDC overview of pertussis (whooping cough) caused by Bordetella pertussis, covering the three clinical stages (catarrhal, paroxysmal, convalescent), transmission, and why infants and unvaccinated individuals are at highest risk.
https://www.cdc.gov/pertussis/about/index.htmlCDC detailed breakdown of pertussis symptoms by stage: early cold-like symptoms (catarrhal stage), severe paroxysmal coughing fits with the characteristic "whoop," and slow recovery (convalescent stage). Used for the symptom sections of the pertussis factsheets.
https://www.cdc.gov/pertussis/signs-symptoms/index.htmlCDC vaccination guidance for pertussis, covering the DTaP series for children and the Tdap booster recommended at age 11–12 and for pregnant women. Pertussis has an R₀ of 12–17, making widespread vaccination essential for herd protection.
https://www.cdc.gov/pertussis/vaccines/index.htmlCDC overview of norovirus — the most common cause of acute gastroenteritis in the U.S. Norovirus causes 19–21 million illnesses and ~900 deaths annually. It is highly contagious: as few as 18 viral particles can cause infection.
https://www.cdc.gov/norovirus/about/index.htmlCDC prevention guidance for norovirus including handwashing (soap is more effective than hand sanitizer), bleach disinfection of contaminated surfaces (1,000–5,000 ppm), proper food handling, and illness exclusion policies for food handlers and students.
https://www.cdc.gov/norovirus/prevention/index.htmlCDC guidance on managing norovirus outbreaks in school and childcare settings, including outbreak thresholds, exclusion timelines (return 48 hours after symptoms resolve), environmental decontamination protocols, and communication strategies.
https://www.cdc.gov/norovirus/outbreak-basics/index.htmlWHO fact sheet on seasonal influenza covering global burden (~1 billion infections annually), mortality (290,000–650,000 respiratory deaths), high-risk groups, and the importance of annual vaccination. Provides global context for the U.S.-focused CDC data.
https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)WHO fact sheet on COVID-19 covering global transmission, symptom spectrum from mild to severe, variants of concern, and ongoing public health guidance. Used to provide global context for the COVID-19 factsheets.
https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19)WHO Western Pacific guidance on asymptomatic and mild COVID-19 cases, noting that some infected individuals never develop symptoms but can still transmit the virus — particularly relevant for school transmission where many students may be asymptomatic.
https://www.who.int/westernpacific/emergencies/covid-19/information/asymptomatic-covid-19WHO fact sheet on RSV covering global burden, clinical spectrum (from mild URI to bronchiolitis and pneumonia), and risk factors. RSV causes an estimated 33 million lower respiratory tract infections in children under 5 globally each year.
https://www.who.int/news-room/fact-sheets/detail/respiratory-syncytial-virus-(rsv)WHO health topic page for pertussis providing global epidemiological overview, vaccine recommendations, and surveillance data. Despite high global vaccination coverage, pertussis remains endemic worldwide with periodic outbreaks.
https://www.who.int/health-topics/pertussis2024 WHO fact sheet reporting approximately 24.1 million pertussis cases annually worldwide, with ~160,700 deaths, predominantly in infants under 1 year. Used for global burden statistics in the pertussis high school factsheet.
https://www.who.int/docs/librariesprovider2/default-document-library/pertussis-factsheet-08022024.pdfWHO page on the global burden of norovirus and the status of vaccine development. Norovirus is the leading cause of acute gastroenteritis globally, causing ~685 million cases and 200,000+ deaths annually, with no licensed vaccine currently available.
https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/norovirusWHO page on GAS (Streptococcus pyogenes) covering global disease burden, including over 300,000 new rheumatic heart disease cases and 150,000+ deaths annually. Reports up to 25% asymptomatic carriage in school-age children.
https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/streptococcus-pyrogenesWHO fact sheet explaining how untreated or repeated strep throat infections can trigger rheumatic fever, which can permanently damage heart valves (rheumatic heart disease). An important complication covered in the strep throat high school factsheet.
https://www.who.int/news-room/fact-sheets/detail/rheumatic-heart-diseaseAAP's foundational school health resource for managing communicable diseases in educational settings. Provides guidance on illness exclusion, outbreak response, and health communication — the foundation for the school-impact sections of every factsheet.
https://www.aap.org/en/patient-care/school-health/managing-infectious-diseases-in-schools/AAP Grand Rounds review of structured handwashing programs in schools, finding a 21% reduction in illness-related absences overall, with reductions of up to 40% for GI illness and 30% for respiratory illness. Used for the Data & Trends prevention effectiveness section.
https://publications.aap.org/aapgrandrounds/article/26/2/14/87859/Hand-Hygiene-in-Schools-Reduces-Influenza-andAAP Pediatrics study confirming that GI and respiratory infections are the primary drivers of illness-related school absences. Findings support the rationale for this project's focus on norovirus, influenza, and other communicable school diseases.
https://publications.aap.org/pediatrics/article/121/6/e1555/72750/Reducing-Absenteeism-From-Gastrointestinal-andLandmark AAP Pediatrics study showing a countywide school-based flu vaccination program led to a 72% reduction in student flu absences and contributed to broader community protection. Source for the vaccination effectiveness data in the Data & Trends page.
https://publications.aap.org/pediatrics/article/122/1/e260/73024/Countywide-School-Based-Influenza-Immunization2025 AAP annual guidance recommending influenza vaccination for all children ≥6 months of age, updating antiviral treatment protocols, and emphasizing school-based vaccination programs as a cost-effective public health intervention.
https://publications.aap.org/pediatrics/article/156/6/e2025073620/202845/Recommendations-for-Prevention-and-Control-of2025 AAP Pediatrics study finding that over 90% of pre-K and elementary school students are affected by at least one respiratory virus detection annually, with influenza, RSV, and rhinovirus being most common. Source for the 90%+ statistic in the Data & Trends overview.
https://publications.aap.org/pediatrics/article/156/4/e2025070886/203957/Respiratory-Virus-Detection-and-Acute-RespiratoryAAP patient care page on RSV prevention for families and healthcare providers, highlighting nirsevimab (Beyfortus) for infants and RSVpreF for pregnant women, along with hygiene measures for preventing spread in school and daycare settings.
https://www.aap.org/en/patient-care/respiratory-syncytial-virus-rsv-prevention/2025 AAP guidance on RSV prophylaxis, including updated recommendations for nirsevimab eligibility, dosing, and priority groups. Provides clinical context for the RSV prevention sections in the high school factsheet.
https://publications.aap.org/pediatrics/article/156/5/e2025073923/203221/Recommendations-for-the-Prevention-of-RSV-DiseaseComprehensive AAP Pediatrics in Review article covering GAS epidemiology, clinical features (pharyngitis, impetigo, scarlet fever), diagnosis, and treatment. Used extensively for the middle and high school strep throat factsheets.
https://publications.aap.org/pediatricsinreview/article/45/3/143/196643/Group-A-Streptococcus-InfectionsAAP Red Book chapter on strep pharyngitis and scarlet fever, covering clinical diagnosis, laboratory testing, antibiotic treatment, and complications. Provides the clinical depth behind the strep throat high school factsheet content.
https://publications.aap.org/aapbooks/monograph/805/chapter/17414599/Strep-Throat-Streptococcal-Pharyngitis-and-ScarletAAP Pediatrics policy statement establishing that school attendance is a social determinant of health. Chronic absenteeism (missing 10%+ of days) is linked to poor academic outcomes, reduced access to meals and therapy, and long-term health disparities. Source for the Data & Trends "Education at Risk" impact card.
https://publications.aap.org/pediatrics/article/143/2/e20183648/37326/The-Link-Between-School-Attendance-and-Good-HealthAAP Pediatrics study reporting that only 28% of female and 8% of male students wash their hands with soap after using the bathroom. Used as the source for the hygiene compliance statistics on the homepage and Data & Trends page.
https://publications.aap.org/pediatrics/article/157/4/e2025071429/206762/Michigan-s-Crusade-for-Clean-Hands-The-ModernAAP Red Book chapter on transmission of communicable diseases in group childcare and school settings, covering rhinovirus, influenza, pertussis, COVID-19, and strep throat. A comprehensive clinical reference for understanding disease spread in school populations.
https://publications.aap.org/redbook/book/755/chapter/14074694/Children-in-Group-Child-Care-and-SchoolsRandomized trial evaluating a structured handwashing program in childcare centers. Supports the evidence base for hand hygiene as an effective intervention for reducing illness-related absences in school-age populations.
https://publications.aap.org/pediatrics/article/142/5/e20181245/38560/Effectiveness-of-a-Hand-Hygiene-Program-at-ChildCDC guidance for early care and education settings on preventing infection spread, including cleaning and disinfection schedules, diaper-changing protocols, and illness exclusion policies relevant to younger school populations.
https://www.cdc.gov/early-care/prevention/protecting-against-infections.htmlWHO surveillance standards document for pertussis, reporting an estimated 24.1 million pertussis cases annually worldwide. Provides the global burden data cited in the pertussis factsheets and the R₀ comparison chart.
https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-pertussis2024 CDC press release announcing updated K–12 school infection prevention guidance, emphasizing layered prevention approaches and evidence-based interventions for respiratory and GI illness control.
https://www.cdc.gov/media/releases/p-0517-guidance-k-12.htmlCDC infection control guidelines for managing norovirus outbreaks in healthcare and community settings, including bleach concentration specifications (1,000–5,000 ppm chlorine) for surface disinfection. Referenced in the norovirus prevention section.
https://www.cdc.gov/infection-control/hcp/norovirus-guidelines/index.htmlAAP's COVID-19 patient care resource hub covering testing, treatment, immunization, Long COVID, and school return guidance. Supplementary source for the COVID-19 factsheets, particularly the school-impact sections.
https://www.aap.org/en/patient-care/covid-19/CDC page on post-streptococcal glomerulonephritis (PSGN), a kidney complication that can develop after GAS infection. Used in the high school strep throat factsheet to explain the serious long-term complications of untreated infection.
https://www.cdc.gov/group-a-strep/about/post-streptococcal-glomerulonephritis.htmlCDC page on rheumatic fever, an inflammatory complication of untreated strep throat that can permanently damage the heart valves. Used to explain why completing antibiotic treatment for strep is critical, even when symptoms improve early.
https://www.cdc.gov/group-a-strep/about/rheumatic-fever.htmlCDC clinical overview for healthcare providers on RSV, covering pathophysiology, incubation period (4–6 days), clinical progression from upper to lower respiratory tract, diagnostic testing, and supportive care. Provides clinical depth for the RSV high school factsheet.
https://www.cdc.gov/rsv/hcp/clinical-overview/index.htmlAll statistics and health information in this project are derived from the official sources listed on this page. No information was self-generated or sourced from unverified websites. Specific statistics are linked to their source in the Data & Trends page. This bibliography can be used for citation in academic submissions.